Stocks to Buy or Sell. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other stocks to buy and sell highlighted in Jim Cramer’s latest calls. Jim Cramer in a latest program on CNBC reminded

Danish businesses are concerned about a possible trade conflict with the United States over Greenland, a major lobby group said on Thursday after business leaders, including CEO of obesity drugmaker Novo Nordisk,

A new weight loss drug from Novo Nordisk helped patients lose a large amount of weight, providing a boost for Novo in the competitive field.

Novo Nordisk (NVO) said its popular diabetes drug Ozempic, or semaglutide, has been approved for the treatment of patients with chronic kidney disease and diabetes. Read more here.

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for its amycretin weight-loss drug.

US stocks closed lower afer the S&P 500 touched an intraday record high early in the day. As tariff worries eased, mixed company news took focus.

It's a big week ahead as the U.S. Federal Reserve, European Central Bank and Bank of Canada hold their first meetings of 2025.

The big hope is that Europe will move faster to implement reforms in the face of competitive threats from the US

Canada's main stock index was subdued on Friday after eight successive winning sessions as falling energy Stocks offset gains elsewhere. The TSX index dipped 0.04 points to start Friday at 25,434.04.

In November 2023 Colombia imposed a tax on highly processed foods and drinks. Authorities in Brazil, Canada and Peru have advised the public to limit consumption of these foods. In Britain parliamentarians are investigating the effects of UPFs on people’s health.

Detailed price information for Texas Instruments (TXN-Q) from The Globe and Mail including charting and trades.

Netflix, whose fourth-quarter earnings published overnight blew past analysts’ forecasts, gained 9.7 per cent, pulling other technology stocks higher. Oracle jumped 6.8 per cent and Microsoft added 4.1 per cent after they joined other tech titans, including OpenAI, in announcing plans for a sweeping new US artificial intelligence project.